Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about INCY

Recent news which mentions INCY

< Previous 1 2 3 4 5 6 7 8 9 Next >
Incyte, Knight Therapeutics Ink Distribution Pact For Two Cancer Drugs In Latin America
Tickers INCY
Tags Market News Contracts General
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021
Tickers AMGN ANNX AOSL ARGX
Tags LIDR DNMR XFLT
From Benzinga
BriaCell's Survival Story Could Mean a Better Chance of Survival for Women Suffering from Breast Cancer
Tickers BCTX INCY
Tags Benzinga Biotech BriaCell Therapeutics
From Benzinga
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
Tickers ABCL ABSI AFIB ALZN
Tags Offerings BNTX SYBX
From Benzinga
10 Biggest Price Target Changes For Thursday
Tickers FDX INCY KBH LEN
Tags Market News Price Target Changes SPT
From Benzinga
Back To Back FDA Approval For Incyte - This Time For Jakafi In GVHD
Tickers INCY
Tags Benzinga Movers Biotech
From Benzinga
Facebook, Incyte Fall Despite the Nasdaq's Strong Wednesday Start
Tickers FB INCY
Tags INCY Market News FB
From Motley Fool
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
Tickers ABEO ABSI AFIB AMAM
Tags News VIVE SMMT
From Benzinga
Incyte's Topical JAK Inhibitor Scores FDA Approval For Atopic Dermatitis
Tickers INCY
Tags General FDA Benzinga
From Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
Tickers ABSI ADTX AERI AFIB
Tags PSTX TCRX VRCA
From Benzinga
Incyte's Pemazyre Wins Conditional Approval For Bile Duct Cancer In Canada
Tickers INCY
Tags News Briefs Benzinga
From Benzinga
Is AbbVie a Bad News Buy?
Tickers ABBV INCY LLY PFE
Tags PFE LLY ABBV
From Motley Fool
The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight
Tickers AGTC APRE BMY BNTX
Tags ONTX VSTM Earnings
From Benzinga
Price Over Earnings Overview: Incyte
Tickers INCY
Tags BZI/PE Markets Market News
From Benzinga
FDA Hits JAK inhibitors With Heart Safety, Cancer Warnings: All You Need To Know
Tickers ABBV BMY INCY LLY
Tags BMY FDA General
From Benzinga
Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates
Tickers ABBV ASND BGNE BIIB
Tags Previews BGNE TEVA
From Benzinga
If you’ve got the stock market jitters, here are 20 companies in two defensive sectors
Tickers ABC AES ANTM BAX
Tags ANTM ABC BMY
From MarketWatch
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
Tickers AGEN ALKS ALZN BLFS
Tags RPHM BLFS RGEN
From Benzinga
Incyte - MorphoSys's Diffuse Large B-Cell Lymphoma Drug Wins European Approval
Tickers INCY MOR
Tags Market News News Health Care
From Benzinga
These 20 ‘left behind’ stocks among the S&P 500 are expected to rise up to 59% over 12 months
Tickers AAPL AMZN ATVI BAX
Tags FIS MSFT SPY
From MarketWatch
BriaCell, ImaginAb Join Forces To Assess Imaging Tech In Breast Cancer Trial
Tickers BCTX INCY
Tags General Movers Biotech
From Benzinga
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Tickers ABSI ABVC ACAD ACHV
Tags EVFM NKTR Benzinga
From Benzinga
Incyte Out Licenses Lymphoma Drug To InnoCare In Greater China
Tickers INCY MOR XNCR
Tags News INCY Health Care
From Benzinga
BriaCell Therapeutics Attacks Cancer with Novel Off-the-Shelf Immunotherapies
Tickers INCY
Tags News Health Care Benzinga
From Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
Tickers ABVC ACAD ACHL ADGI
Tags TLGT IPOs ADGI
From Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Tickers ABCL ACET ACHV ADGI
Tags TRVI CTMX FULC
From Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
Tickers ACAD ACHV ADMA AKRO
Tags CYCC MNKD GLUE
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Tickers ACAD AKRO APEI ARNA
Tags SDC CTMX Intraday Update
From Benzinga
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
Tickers ACET ADGI AKRO AKYA
Tags PFE HALO MRVI
From Benzinga
Is the PD-(L)1 Party Over After Incyte's FDA Rejection?
Tickers BMY INCY L MRK
Tags MRK BMY INCY
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.